Department of Surgery, University of South Alabama, Mobile, Alabama, USA.
Dis Colon Rectum. 2010 May;53(5):798-802. doi: 10.1007/DCR.0b013e3181d43b7d.
This study was undertaken to determine the long-term outcomes of patients whose anal fistulas were managed by use of bioprosthetic plugs.
A retrospective analysis was performed of all patients whose anal fistula was managed by use of a bioprosthetic plug between May 2005 and September 2006, who had a minimum of 1 year of follow-up since their last treatment. Patients whose fistulas were clinically healed were offered MRI to confirm healing of the fistula.
The bioprosthetic fistula plug was used to treat an anal fistula in 63 patients with clinical healing of the fistula in 51 (81%). Multivariate analysis showed that tobacco smoking, posterior fistula, and history of previous failure of the bioprosthetic plug was predictive of failure of the bioprosthetic plug. Eight patients with clinical healing after a minimum of 1 year since their last treatment underwent MRI. No evidence of residual fistula tract or fluid in the area of the previous fistula was found in 6 (75%) of these patients.
Bioprosthetic plugs are effective for the long-term closure of complex fistulas-in-ano. Randomized clinical trials comparing bioprosthetic plugs with other sphincter-preserving methods for fistula management need to be conducted to further determine the role of bioprosthetics in the management of anal fistulas.
本研究旨在确定采用生物假体塞治疗的肛门瘘患者的长期结果。
对 2005 年 5 月至 2006 年 9 月期间采用生物假体塞治疗的所有肛门瘘患者进行回顾性分析,这些患者在最后一次治疗后至少有 1 年的随访。临床治愈的瘘管患者被提供 MRI 以确认瘘管的愈合。
生物假体瘘管塞用于治疗 63 例肛门瘘患者,51 例(81%)临床治愈。多变量分析表明,吸烟、后位瘘和生物假体塞既往失败史是生物假体塞失败的预测因素。8 例患者在最后一次治疗后至少 1 年临床治愈后接受了 MRI。在这 6 例(75%)患者中,未发现以前瘘管部位有残留瘘管或液体。
生物假体塞可有效长期闭合复杂的肛门瘘。需要进行生物假体与其他保留括约肌方法治疗瘘管的随机临床试验,以进一步确定生物假体在肛门瘘管理中的作用。